Eiermann T H
Red Cross Blood Bank, Department of Transplantation Immunology, Ulm, Germany.
Arch Immunol Ther Exp (Warsz). 1995;43(2):83-7.
Bone marrow transplantation between HLA-identical siblings is an established therapeutic strategy in leukemia and a variety of lympho-hematopoietic disorders. In recent years unrelated donors were increasingly used for patients lacking a family donor. Here we report on current progress in HLA class II typing by molecular methods which have influenced donor search and improved matching.
在 HLA 相同的同胞间进行骨髓移植是白血病及多种淋巴造血系统疾病的既定治疗策略。近年来,对于没有家族供者的患者,越来越多地使用无关供者。在此,我们报告分子方法在 HLA Ⅱ类分型方面的当前进展,这些进展影响了供者寻找并改善了配型。